Win a $50,000 3D I/O Pro™ research grant from Alpenglow

Written By Guest User

Alpenglow Biosciences has developed the 3D I/O Pro™ assay to quantitatively assess tissue heterogeneity in the study of immuno-oncology, disease pathogenesis, and treatment response. To accelerate the development of novel therapeutics and next generation research in the important field of immuno-oncology, Alpenglow is launching a $50,000 research grant program, open to scientists worldwide, to leverage the 3D I/O Pro™ assay to unlock novel biological insights with 3D spatial biology.

Learn more about the research program and how the 3D I/O Pro™ assay can help accelerate your drug discovery and clinical programs.  3D I/O Pro™ assay is for Research Use Only (RUO).  Not for use in diagnostic procedures.  

Application Deadline: Wednesday, April 24, 2024

Guest User
Previous

Final Agenda Announced for the 3D Spatial Summit 2024: Join Leading Academics and Industry Experts on October 17th in Cambridge, MA
Next

Alpenglow Biosciences Announces Immediate Availability of 3D Derm Score Assay for Research into complex diseases of the skin